SCP.WA Stock Analysis
SC
Uncovered
Scope Fluidics SA is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Scope Fluidics SA engages in the research and development in the field of healthcare. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 30 full-time employees. The company went IPO on 2017-08-16. The firm focuses on diagnostic and med-tech solutions. The company develops disposable microfluidic systems for the collection of micro-samples of blood, as well as storage of reagents for diagnostic markers. Its projects include PCR ONE system that delivers the bacterial and viral pathogen detection, and BacterOMIC system that delivers information on bacterial susceptibility to antibiotics and on the resistance mechanisms. The firm provides access to laboratories and workshops for developed projects, as well as administrative facilities and services, including financing. In addition, it cooperates with doctors, medical personnel, project managers, engineers and academics.